Conmed (NASDAQ: CNMD) reported Q2 EPS of ($0.07), $0.88 better than the analyst estimate of ($0.95). Revenue for the quarter came in at $157.8 million versus the consensus estimate of $126.59 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.